The global quinidine sulfate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Quinidine sulfate is used for the treatment of certain types of irregular heartbeats. It is in a class of medications called antiarrhythmic medications and works by making the heart more resistant to abnormal activity. The major factor driving the demand for quinidine sulfate is the increasing prevalence of arrhythmia and other diseases such as malaria that require quinidine sulfate treatment across the globe. 

Moreover, the growth of the market can also be attributed to the increasing awareness of the usage and appropriate dosage of quinidine sulfate supplements among people globally. Additionally, the function of quinidine sulfate involves blocking the fast inward sodium current that is dependent upon the use. For instance, at higher heart rates, the block increases, and at lower heart rates, the block decreases. Further, the growth of the market is hampered due to side effects associated with quinidine sulfate such as diarrhea, nausea, vomiting, loss of appetite, stomach pain/cramps, among others. 

Some major players in the market include Pfizer Inc., Novartis International AG, and Lupin Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2019, Avanir Pharmaceuticals, Inc. announced the results from the first study of its phase 3 clinical development program investigating the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of moderate-to-severe agitation in patients with Alzheimer's dementia.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Route of Administration
• By Application
• By End-User

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- Pfizer Inc., Novartis International AG, and Lupin Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Quinidine Sulfate Market Report by Segment

By Route of Administration 

• Oral Administration
• Intravenous Administration
• Others

By Application 

• Arrhythmias
• Malaria
• Others

By End-User 

• Pediatrics 
• Adults

Global Quinidine Sulfate Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France

Rest of Europe 

• Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa